by admin | Jul 20, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By The Harvard Gazette For more than 20 years, scientists have been able to unravel the sequence of the human genome, the precise recipe of everyone’s DNA. That has led to incredible advances in discovering genes responsible for countless diseases. But within the last...
by admin | Jul 19, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Growing and selection are crucial. by Josh Conway – Lifespan.io CRISPR is still imperfect While the accuracy of genetic modification through the well-known CRISPR/Cas9 system continues to improve, the technology remains imperfect. Small mistakes were initially...
by admin | Jul 18, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
— Difficult infection took weeks to identify; doctors warn about unproven treatments by Sophie Putka – MedPage Today A woman with multiple sclerosis (MS) who had intrathecal injections of umbilical cord stem cells in Mexico ended up with a severe Mycobacterium...
by admin | Jul 17, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by William A. Haseltine – Forbes Induced pluripotent stem cells (iPSC), a continuing muse in cell therapy research, could potentially be used to improve flaws associated with conventional CAR T therapy. What if an effective cancer treatment became cheaper and...
by admin | Jul 15, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Izzy Wood – Drug Target Review US researchers combine revascularisation techniques to allow new blood vessels to rapidly form in an architecturally organised manner. The ability to regenerate and pattern blood vessels remains an elusive milestone in...
by admin | Jul 14, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Genetic and Engineering News Alzheimer’s disease (AD) is the sixth leading cause of death in the United States. However, the exact cause of AD remains unknown. Existing approved treatments for AD are designed to target the already existing AD neuropathology,...
